DK0545511T3 - Process for the preparation of mono-N-substituted tetraazamacrocycles - Google Patents

Process for the preparation of mono-N-substituted tetraazamacrocycles

Info

Publication number
DK0545511T3
DK0545511T3 DK92250351T DK92250351T DK0545511T3 DK 0545511 T3 DK0545511 T3 DK 0545511T3 DK 92250351 T DK92250351 T DK 92250351T DK 92250351 T DK92250351 T DK 92250351T DK 0545511 T3 DK0545511 T3 DK 0545511T3
Authority
DK
Denmark
Prior art keywords
mono
preparation
tetraazamacrocycles
substituted
substituted tetraazamacrocycles
Prior art date
Application number
DK92250351T
Other languages
Danish (da)
Inventor
Heinz Dr Gries
Johannes Dr Platzek
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Application granted granted Critical
Publication of DK0545511T3 publication Critical patent/DK0545511T3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

A novel process for the preparation of mono-N-substituted tetraazamacrocycles is described.
DK92250351T 1991-12-06 1992-12-03 Process for the preparation of mono-N-substituted tetraazamacrocycles DK0545511T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4140779A DE4140779A1 (en) 1991-12-06 1991-12-06 METHOD FOR PRODUCING MONO-N SUBSTITUTED TETRAAZAMACROCYCLES

Publications (1)

Publication Number Publication Date
DK0545511T3 true DK0545511T3 (en) 2002-08-12

Family

ID=6446767

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92250351T DK0545511T3 (en) 1991-12-06 1992-12-03 Process for the preparation of mono-N-substituted tetraazamacrocycles

Country Status (13)

Country Link
EP (1) EP0545511B1 (en)
JP (1) JP3471836B2 (en)
AT (1) ATE218131T1 (en)
CA (1) CA2084582C (en)
CZ (1) CZ290232B6 (en)
DE (2) DE4140779A1 (en)
DK (1) DK0545511T3 (en)
ES (1) ES2176183T3 (en)
HU (2) HU9203860D0 (en)
IL (1) IL103996A (en)
NO (5) NO303496B1 (en)
PT (1) PT545511E (en)
SK (1) SK282386B6 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4237943C2 (en) * 1992-11-06 1997-10-23 Schering Ag Process for the preparation of metal complexes of N-beta-hydroxyalkyl-tri-N-carboxyalkyl-1,4,7,10-tetraazacyclododecane and N-beta-hydroxyalkyl-tri-N-carboxyalkyl-1,4,8,11-tetraazacyclotetradecane Derivatives
DE4317588C2 (en) * 1993-05-24 1998-04-16 Schering Ag Macrocyclic metal complexes containing fluorine, process for their preparation and their use
DE4318369C1 (en) * 1993-05-28 1995-02-09 Schering Ag Use of macrocyclic metal complexes as temperature probes
DE4340809C2 (en) * 1993-11-24 2000-08-03 Schering Ag 1.4,7,10-tetraazacyclododecane derivatives, pharmaceutical compositions containing them and process for their preparation
FR2725449B1 (en) * 1994-10-05 1996-12-27 Air Liquide POLYAZACYCLOALCANE DERIVATIVES, THEIR METAL COMPLEXES AND PHARMACEUTICAL PRODUCTS INCORPORATING THESE COMPLEXES
DE19724186C2 (en) * 1997-06-02 2002-07-18 Schering Ag Process for the mono- and 1,7-bis-N-ß-hydroxyalkylation of cycles and the corresponding N-ß-hydroxyalkyl-1,4,7,10-tetraazacyclododecane-Li salt complexes
IT1297035B1 (en) * 1997-12-30 1999-08-03 Bracco Spa 1,4,7,10-TETRAAZACICLODODECAN-1,4-DIACETIC ACID DERIVATIVES
DE19914101C1 (en) * 1999-03-22 2000-10-12 Schering Ag Perfluoroalkylamides, their preparation and their use in diagnostics
DE10002939C1 (en) * 2000-01-13 2001-09-20 Schering Ag New aromatic-substituted tetraazacyclododecane-triacetic acid paramagnetic metal complex compounds, are useful as contrast agents for magnetic resonance imaging of necrotic or infarction tissue
WO2012027727A2 (en) * 2010-08-26 2012-03-01 Kunyuan Cui Lipomacrocycles and uses thereof
KR102003570B1 (en) 2011-04-21 2019-07-24 바이엘 인텔렉쳐 프로퍼티 게엠베하 Preparation of high-purity gadobutrol
KR101653064B1 (en) * 2014-12-26 2016-09-09 에스티팜 주식회사 A Method for Gadobutrol
KR102033964B1 (en) * 2018-01-19 2019-10-18 주식회사 엔지켐생명과학 Gadoteridol intermediate and method for preparing gadoteridol using the same

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0232751B1 (en) * 1986-01-23 1991-09-11 E.R. Squibb & Sons, Inc. 1-substituted-4,7,10-triscarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs
DE3625417C2 (en) * 1986-07-28 1998-10-08 Schering Ag Tetraazacyclododecane derivatives
US4994560A (en) * 1987-06-24 1991-02-19 The Dow Chemical Company Functionalized polyamine chelants and radioactive rhodium complexes thereof for conjugation to antibodies
FR2644453A1 (en) * 1989-03-20 1990-09-21 Centre Nat Rech Scient PROCESS FOR THE PREPARATION OF MONOFUNCTIONALIZED CYCLIC TETRAMINES
AU625529B2 (en) * 1989-12-22 1992-07-16 E.R. Squibb & Sons, Inc. 10-(2'-hydroxy-3'-alkoxy-1,4,7-triscarboxymethyl-1,4,7,10- tetraazacyclododecanes
NZ236267A (en) * 1989-12-22 1992-12-23 Squibb & Sons Inc 10-(2'-hydroxy-3'-polyoxaalkyl)-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane
DE4009119A1 (en) * 1990-03-19 1991-09-26 Schering Ag 1,4,7,10-TETRAAZACYCLODODECANE-BUTYLTRIOLS, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL AGENTS CONTAINING THEM
DE4035760A1 (en) * 1990-11-08 1992-05-14 Schering Ag MONO-N-SUBSTITUTED 1,4,7,10-TETRAAZACYCLODODECAN DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL AGENTS CONTAINING THEM

Also Published As

Publication number Publication date
DE59209957D1 (en) 2002-07-04
DE4140779A1 (en) 1993-06-09
CZ290232B6 (en) 2002-06-12
NO303386B1 (en) 1998-07-06
NO973578L (en) 1993-06-07
SK282386B6 (en) 2002-01-07
NO924690L (en) 1993-06-07
NO973578D0 (en) 1997-08-04
JPH05279349A (en) 1993-10-26
EP0545511A3 (en) 1993-11-03
NO973579L (en) 1993-06-07
NO303496B1 (en) 1998-07-20
EP0545511B1 (en) 2002-05-29
PT545511E (en) 2002-10-31
CA2084582C (en) 2005-09-20
CZ357392A3 (en) 1993-08-11
NO303384B1 (en) 1998-07-06
ES2176183T3 (en) 2002-12-01
SK357392A3 (en) 1993-08-11
NO303385B1 (en) 1998-07-06
ATE218131T1 (en) 2002-06-15
NO973580D0 (en) 1997-08-04
NO303387B1 (en) 1998-07-06
HU224923B1 (en) 2006-04-28
HUT65526A (en) 1994-06-28
NO973580L (en) 1993-06-07
IL103996A (en) 1998-02-08
EP0545511A2 (en) 1993-06-09
NO973581L (en) 1993-06-07
CA2084582A1 (en) 1993-06-07
NO924690D0 (en) 1992-12-04
IL103996A0 (en) 1993-05-13
NO973579D0 (en) 1997-08-04
NO973581D0 (en) 1997-08-04
JP3471836B2 (en) 2003-12-02
HU9203860D0 (en) 1993-03-29

Similar Documents

Publication Publication Date Title
NO20016226D0 (en) Process for Preparation of Substituted Formamides
DK0791571T3 (en) benzoyl
ES2093361T3 (en) TREATMENT OF NEURODEGENERATIVE DISEASES.
DK0672670T3 (en) Process for the preparation of clavulanic acid
DK0545511T3 (en) Process for the preparation of mono-N-substituted tetraazamacrocycles
DK0670835T3 (en) Process for the preparation of benzopyran compounds
DK0421081T3 (en) Process for Preparation of 23- (C1-C6-Alkyloxime) -LL-F28249 Compounds
DK0655454T3 (en) Process for the preparation of 2,2-difluorocetensilyl acetals and alpha, alpha-difluoro-beta-silyloxy-1,3-dioxolane-4-propanoic acid esters
DK0638068T3 (en) Process for the preparation of (S) -3-amino-1-substituted-pyrrolidines
DK0501774T3 (en) Preparation of substituted tetrahydropyridines
DK0596586T3 (en) Process for the preparation of metal complexes of N-beta-hydroxyalkyl-tri-N-carboxyalkyl-1,4,7,10-tetraazacyclododecane and N-beta-hydroxyalkyl-tri-N-carboxyalkyl-1,4,8,11-tetraazacyclotetradecane derivatives.
DK0648738T3 (en) Process for the preparation of acetoacetarylamides
DE69115090T2 (en) Process for the preparation of fluoromethyl-substituted pyridine-carbodithioates.
DK0648748T3 (en) Process for Preparation of 5-Acetoacetylaminobenzimidazolone-2
MX9302878A (en) PROCEDURE FOR THE PREPARATION OF A SUBSTITUTED DIAMINODIOL.
DK0635490T3 (en) Process for the preparation of N-ethylcarbazole
ES2089176T3 (en) PROCEDURE FOR THE PREPARATION OF FLUOROMETIL-SUBSTITUTED PIPERIDINE CARBODITIOATES.
ATE119394T1 (en) USE OF MYRICETIN-3-0-BETA-D-GLUCURONIDE AS A MEDICINAL PRODUCT.
DK0569701T3 (en) Process for the preparation of 2-amino-5-methyl-pyridine
DK0599044T3 (en) Process for the preparation of chlorophenylphosphanes
DK0611757T3 (en) Process for the preparation of azaphenothiazines
DK0582977T3 (en) Process for the preparation of 1,3-dialkyl-5-hydroxyoxindoles and ether derivatives thereof